DMC1 and endometrial cancer: Among the protective genes, there was no significant correlation between high DMC1 expression and endometrial cancer patient prognosis (P=0.10, Supplementary Figure 1), while patients with high TLE2 expression had significantly better prognosis (P=0.0014, Supplementary Figure 1).